Navigation Links
Maryland Stem Cell Research Commission Issues 2012 Requests for Applications (RFAs)
Date:10/13/2011

COLUMBIA, Md., Oct. 13, 2011 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) released its 2012 Requests for Applications (RFAs) last week for funding through the Maryland Stem Cell Research Fund (MSCRF). This is the sixth round of funding from the MSCRF.

Established under the Maryland Stem Cell Research Act of 2006, the MSCRF is currently budgeted to commit up to $12.4 million, in aggregate, in FY 2012 to fund grants under all of its RFAs. The Commission last week released three new RFAs, seeking applications for basic, translational and clinical research involving human stem cells of all types, as defined in the Maryland Stem Cell Research Act. Investigators affiliated with Maryland-based organizations of all types are eligible to apply, including public and private for-profit and not-for-profit universities, colleges, research institutes, companies and medical centers.

"Our grant opportunities support Maryland researchers as they conduct cutting-edge research," said Dan Gincel, director of the MSCRF. "This year, we are calling on companies across the country to look into our programs and to consider joining Maryland's thriving biotechnology sector. We believe the scientific community here, combined with our stem cell funding, make Maryland a premier destination for biotech businesses."

RFA-MD-12-1 is soliciting applications for Investigator-Initiated Research Grants, which are designed for investigators with preliminary data supporting the grant application. Investor-Initiated Research Grants provide up to $200,000 of direct costs per year over a maximum of three years.

RFA-MD-12-2 is soliciting applications for Exploratory Research Grants, which are designed for investigators who are new to the stem cell field (young investigators and investigators from other fields), and for new hypotheses, approaches, mechanisms or models that may differ from current thinking in the stem cell field, with little or no preliminary data supporting the application. These Exploratory Research Grants provide up to $100,000 of direct costs per year, for up to two years.

RFA-MD-12-3 is soliciting applications for post-doctoral fellows who wish to conduct research in Maryland. Post-doctoral Fellowship awards provide up to $55,000 per year, for up to two years, including all direct, indirect and fringe benefits costs.

The work funded under these RFAs must be conducted in Maryland. The scientists and clinicians conducting this work must be employed or retained by an eligible Maryland-based organization while the work is ongoing.

All principal investigators funded under these RFAs will be required to present their interim and final research results at an annual in-state symposium and in annual reports to the MSCRF.

Key Dates:

  • Required Letter of Intent Submission Deadline: 11:59 p.m., November 14, 2011
  • Application Submission Deadline: 11:59 p.m., January 16, 2012
  • Peer Review Date(s): March 2012
  • Commission Review Date: May 7, 2012
  • Earliest Anticipated Start Date: June 2012

For more information about the 2012 RFAs, visit the MSCRF Web site at http://www.mscrf.org.

About the Maryland Stem Cell Research Commission

The Maryland Stem Cell Research Fund (MSCRF) was established by the State of Maryland under the Maryland Stem Cell Research Act of 2006 to promote State-funded stem cell research and cures through grants and loans to public and private entities in the State. Administered by the Maryland Technology Development Corporation (TEDCO), the MSCRF is overseen by an independent Commission that sets policy and develops criteria, standards and requirements for applications to the Fund. The current MSCRF budget for FY 2012 is $12.4 million. For more information about the MSCRF and a list of Commission members, please visit http://www.mscrf.org.

Media Contacts:

Kathleen Shaffer
410-902-5053
kshaffer@mghus.com

Kelly Cahill
410-504-8312
kcahill@mghus.com  

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Maryland Stem Cell Research Commission
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mtech TAP Company CosmosID™ Wins Best Life Sciences Company in the Maryland Incubator Company of the Year Awards
2. Maryland Stem Cell Research Commission Funds 36 New Projects in FY 2011
3. Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland
4. Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition
5. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
6. The University of Maryland Baltimore (UMB) and Paragon Bioservices, Inc. Announce the Formation of a Public-Private Stem Cell Technology Consortium
7. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
8. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
9. Maryland Governor Martin OMalley to Visit Novavax in Celebration of HHS-BARDA Contract Award
10. Biophysical Society to Hold 55th Annual Meeting in Baltimore, Maryland, March 5-9, 2011
11. CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eurofins announces the appointment of Sean Murray ... Scientific Inc. (ESI). Mr. Murray will bring valuable ... entrepreneurial experience in leading international business teams. As the National Division ... to uphold Eurofins, status as the global leader in bio-analytical testing ... , , ...
(Date:12/8/2016)... 8, 2016  Anaconda BioMed S.L., a pre-clinical stage ... next generation neuro-thrombectomy system for the treatment of Acute ... Jovin, MD to join its Scientific Advisory Board (SAB). ... network of scientific and clinical experts to Anaconda BioMed ... ANCD BRAIN ® to its clinical phase. The ...
(Date:12/8/2016)... PRINCETON, N.J. , Dec. 8, 2016 /PRNewswire/ ... a late-stage biopharmaceutical company focused on developing and ... is an unmet medical need, announced today the ... trial with SGX942 (dusquetide), a first-in-class Innate Defense ... (OM) in head and neck cancer patients undergoing ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
(Date:11/29/2016)... 29, 2016   Neurotechnology , a ... recognition technologies, today released FingerCell 3.0, a ... solutions that run on low-power, low-memory microcontrollers. ... less than 128KB of memory, enabling it ... have limited on-board resources, such as: mobile ...
Breaking Biology News(10 mins):